DAA1085 |
Rhomboid Domain Containing 1 |
Molecular |
cerebellum |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1081 |
Dipeptidyl-peptidase 8 |
Molecular |
cerebellum |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA1101 |
Myogenic Differentiation 1 |
Molecular |
cerebellum |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1113 |
Growth Arrest-specific 2 Like 3 |
Molecular |
cerebellum |
Human |
GAS2L3 |
Increase DNA Methylation |
|
DAA1077 |
Pipecolic Acid Oxidase |
Molecular |
cerebellum |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA1093 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
cerebellum |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1089 |
ATP/GTP Binding Protein-like 5 |
Molecular |
cerebellum |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
pons |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1095 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
pons |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1103 |
Myogenic Differentiation 1 |
Molecular |
pons |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1083 |
Dipeptidyl-peptidase 8 |
Molecular |
pons |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA1087 |
Rhomboid Domain Containing 1 |
Molecular |
pons |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1115 |
Growth Arrest-specific 2 Like 3 |
Molecular |
pons |
Human |
GAS2L3 |
Increase DNA Methylation |
|
DAA1111 |
Dickkopf-like 1 |
Molecular |
pons |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA1091 |
ATP/GTP Binding Protein-like 5 |
Molecular |
pons |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA1079 |
Pipecolic Acid Oxidase |
Molecular |
pons |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA1099 |
Schlafen Family Member 11 |
Molecular |
pons |
Human |
SLFN11 |
Increase DNA Methylation |
|
DAA1981 |
Selective increase in oxidative damage and decrease in antioxidant function during aging in the substantia nigra |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA722 |
Accumulation of neuromelanin in dopaminergic nigral neurons |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
Molecular |
hippocampus |
Human |
CXCL5 |
64.9% Increase Gene Expression Level |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
hippocampus |
Human |
CX3CL1 |
31.6% Decrease Gene Expression Level |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
hippocampus |
Human |
CXCL16 |
100.6% Increase Gene Expression Level |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|